/PRNewswire/ -Geneseeq Technology Inc. announced that Geneseeq s multi-cancer minimal residual disease detection (MRD) and multi-cancer early detection (MCED).
/PRNewswire/ - Geneseeq Technology Inc. ("Geneseeq"), a company focused on advancing cancer genomic profiling through cutting-edge next-generation based.
/PRNewswire/ - Geneseeq Technology Inc. ("Geneseeq"), a company focused on advancing cancer genomic profiling through cutting-edge next-generation based.
Cancer Diagnostics Market is projected to expand at a CAGR of 7.1% and gain a revenue worth US$ 191 Bn during the forecast period | Future Market Insights,